These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36496345)

  • 1. Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Respir Investig; 2023 Mar; 61(2):284-295. PubMed ID: 36496345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Sci Rep; 2024 May; 14(1):10162. PubMed ID: 38702426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
    Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
    PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy.
    Minegishi Y; Takenaka K; Mizutani H; Sudoh J; Noro R; Okano T; Azuma A; Yoshimura A; Ando M; Tsuboi E; Kudoh S; Gemma A
    Intern Med; 2009; 48(9):665-72. PubMed ID: 19420811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias.
    Minegishi Y; Kuribayashi H; Kitamura K; Mizutani H; Kosaihira S; Okano T; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
    J Thorac Oncol; 2011 Apr; 6(4):801-7. PubMed ID: 21336181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
    Arai T; Kida H; Ogata Y; Marumo S; Matsuoka H; Gohma I; Yamamoto S; Mori M; Sugimoto C; Tachibana K; Akira M; Edahiro R; Hamasaki T; Inoue Y;
    Respirology; 2019 Jul; 24(7):658-666. PubMed ID: 30835911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
    Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
    Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.
    Sand JMB; Tanino Y; Karsdal MA; Nikaido T; Misa K; Sato Y; Togawa R; Wang X; Leeming DJ; Munakata M
    Respir Res; 2018 May; 19(1):82. PubMed ID: 29728109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative assessment of the patient with restrictive lung disease].
    Fukuoka N; Iida H
    Masui; 2010 Jul; 59(7):833-7. PubMed ID: 20662280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of lung cancer surgery for patients with interstitial pneumonia and coronary disease.
    Fukui M; Takamochi K; Suzuki K; Ando K; Matsunaga T; Hattori A; Oh S; Suzuki K
    Surg Today; 2022 Jan; 52(1):137-143. PubMed ID: 34136963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    Nathan SD; Cottin V; Behr J; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Ley-Zaporozhan J; Müller-Lisse UG; Scholle FD; Brüggenwerth G; Busse D; Nikkho S; Wells AU
    J Heart Lung Transplant; 2021 Jun; 40(6):494-503. PubMed ID: 33744088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic lymphoma kinase inhibitor related pneumonitis in patients with non-small cell lung cancer: Clinical and radiologic characteristics and risk factors.
    Hwang HJ; Kim MY; Choi CM; Lee JC
    Medicine (Baltimore); 2019 Nov; 98(48):e18131. PubMed ID: 31770246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias.
    Minegishi Y; Sudoh J; Kuribayasi H; Mizutani H; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
    Lung Cancer; 2011 Jan; 71(1):70-4. PubMed ID: 20493578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.
    Hozumi H; Enomoto N; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Lung; 2016 Apr; 194(2):235-42. PubMed ID: 26873743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
    Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.
    Fujimoto D; Morimoto T; Ito J; Sato Y; Ito M; Teraoka S; Otsuka K; Nagata K; Nakagawa A; Tomii K
    Lung Cancer; 2017 Sep; 111():1-5. PubMed ID: 28838377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
    Yamagata A; Arita M; Tachibana H; Tokioka F; Sugimoto C; Sumikawa H; Tanaka T; Yasui H; Fujisawa T; Nakamura Y; Suda T; Ishida T
    Respir Res; 2021 Apr; 22(1):115. PubMed ID: 33879137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.